In 1998, SH2D1A, which encodes the signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), was identified as the first pathogenic gene associated with XLP. This evidence concerns the gene SH2D1A and X-linked lymphoproliferative disease.